Grants for Special district governments - Health

This grant provides funding for researchers to study how the combined stigma of HIV and cancer affects health outcomes in HIV-positive individuals diagnosed with cancer, with a focus on developing interventions to reduce this stigma.

This grant provides funding for research projects that explore how sex hormones affect HIV progression and substance use disorders, aiming to develop new therapeutic strategies for these interconnected health issues.

This funding opportunity supports primary care centers in implementing genomic screening for common genetic conditions to improve disease prevention and care, particularly in underrepresented communities.

This funding opportunity supports innovative research projects that explore how sex hormones affect the relationship between HIV and substance use disorders, targeting scientists and institutions focused on molecular biology and addiction.

This funding opportunity supports research on the combined effects of HIV and cancer stigma on health outcomes for individuals living with HIV who have been diagnosed with cancer, encouraging innovative interventions to improve their care and support.

This funding opportunity supports researchers investigating how single-cell responses to HIV and addictive substances, like opioids, affect brain function and health, with a focus on data mining and functional validation studies.

This funding opportunity supports researchers in exploring and validating the biological mechanisms linking HIV, substance use disorders, and opioid exposure at a single-cell level, with a focus on data mining existing datasets and conducting functional validation studies.

The Arizona Department of Health Services (ADHS) Bureau of Women’s and Children’s Health (BWCH) oversees Adolescent Health programming to improve the health and well-being of young people in the state. As of 2005, BWCH has been administering state lottery funds for the prevention of teen pregnancies and sexually transmitted infections (STIs). According to the Arizona Vital Statistics, from 2011 to 2021, the teen birth rate for Arizona teenagers ages fifteen through nineteen (15-19) has declined from thirty-six point nine (36.9) to fifteen point three (15.3) per 1,000 females. The repeat birth rates of youth of the same age, who had already had a child decreased from 142.7 in 2011 to 135.8 per 1,000 in 2021. Despite the declines, birth rates for Arizona teens ages fifteen through nineteen (15-19)   exceeds   the   national   rate   of   thirteen   point   nine   (13.9)   in   2021 (https://blogs.cdc.gov/nchs/2023/01/20/7245/). Arizona's racial and ethnic groups exhibit significant disparities in teen pregnancy rates, with Hispanic, American Indian, and African American females aged nineteen (19) or younger experiencing the highest rates. In 2021, American Indian youth had a notably elevated pregnancy rate of sixteen point three (16.3) per 1,000 females, surpassing the state average of ten point six (10.6) per 1,000. Similarly, rates for Hispanic or Latino youth were fourteen point four (14.4) per 1,000, and for Black or African American youth, they were twelve point six (12.6) per 1,000, both above the state average, while rates for White Non-Hispanics six (6) per 1,000 and Asian or Pacific Islanders three point four (3.4) per 1,000 were considerably lower. Teen pregnancy is intricately linked with complex factors such as school failure, behavioral issues, and family challenges, which often hinder youths’ ability to avoid pregnancy. Positive Youth Development (PYD) programs present a promising approach by emphasizing the enhancement of protective factors over merely addressing risk behaviors. These programs have shown efficacy in reducing sexual risk behaviors, Human immunodeficiency virus (HIV), other sexually transmitted diseases (STDs), and unintended pregnancies. By fostering ongoing development and maturation, PYD programs empower youth to recognize and manage risk-taking behaviors, making them a viable strategy for teen pregnancy prevention (Gavin et al., 2010). According to the 2021 Arizona Surveillance STD case data, forty-nine percent (49%) of STD cases (chlamydia, gonorrhea, and syphilis) in Arizona were among adolescents under the age of twenty-five (25). Since 2019, the rate of chlamydia among teenagers fifteen through nineteen (15-19) years old has been slowly decreasing but still remains high at 2,031 per 100,000 in 2019 to 1,729 per 100,000 in 2021. For gonorrhea, the rate among these teenagers increased from 384 per 100,000 in 2019 to 467 per 100,000 in 2021. As for syphilis, in 2019, twenty-two (22) per 100,000 fifteen through nineteen (15-19) year-old teenagers were reported to have syphilis, increasing to twenty-six (26) per 100,000 in 2021. Regarding STDs/STIs, major disparities between Arizona’s racial and ethnic groups also persist. The Arizona 2021 Annual STD Report indicates that Black (994 per 100,000) and American Indian/Alaska Native (787 per 100,000) populations have consistently higher rates of chlamydia, the Black population (763 per 100,000) continues to have the highest rate of gonorrhea, and the American Indian/Alaska Native (172 per 100,000) and Black (123 per 100,000) populations have the highest rates of syphilis, surpassing their Hispanic, White, and Asian/Pacific Islander counterparts. Financial Notes: Approximately $700,000.00 will be available each Grant year for a five (5) year grant period to provide services to youth for the prevention of teen pregnancies and STIs. Annual funding for services will be provided during the state fiscal year, from July through June; Therefore, the first and last years of funding will be partial funding: first year funded upon award through June 30, 2025; fifth year from July 1, 2029 through September 30, 2029. Budgets will be reviewed annually and may be decreased based on: 1. Changes in state lottery funding allocations. 2. Failure to meet the number of youths proposed to be served; or meet the required program completion by youth for Teen Pregnancy Prevention Programming. 3. Failure to comply with Grant requirements. 4. Negative audit findings. 5. Failure to spend budget funds efficiently.

This grant provides funding for researchers to explore the genetic and molecular factors influencing addictive behaviors and substance use disorders, with the goal of identifying new therapeutic targets and strategies.

This funding opportunity supports researchers working on developing and optimizing genome editing therapies for various forms of Alzheimer's Disease-Related Dementias, aiming to advance these treatments towards clinical use.

This funding opportunity supports collaborative research teams of diverse experts to tackle ambitious challenges in dental, oral, and craniofacial science, focusing on innovative solutions like non-opioid pain therapies and health disparity-reducing technologies.

The purpose of the Health Financing Activity (HFA) is to improve access to equitable and quality health services and prevent catastrophic health expenditure through increased resources for health, efficient allocation and utilization, and enhanced financial risk protection in alignment with Ethiopias overall aim of achieving Universal Health Coverage (UHC) through Primary Health Care (PHC) by 2035. Health care financing reform in Ethiopia, initiated in 1998, aimed to improve the quality and equity of health services. The strategy focused on increasing resources for health care, promoting efficiency, and ensuring long-term sustainability through multiple financing mechanisms. Key interventions included revenue retention at health facilities, a fee-waiver system, standardized exemption services, and the introduction of health insurance schemes. These reforms have significantly improved health service delivery and financial protection for citizens. USAIDs investments in healthcare financing reform are largely focused on strengthening and institutionalizing health care financing (HCF) functions and systems to support universal health coverage of quality primary health care (PHC) services for Ethiopian citizens with reduced financial barriers. The HFA will build upon the lessons derived from previous USAID Ethiopia Health Care financing reform initiatives, including the recent five-year Health Financing Improvement Program (HFIP). The expected outcomes will be evidence-based and objectively measured through the progress made in the country's capacity to achieve sufficient, equitable, sustainable, and efficient financing for universal healthcare coverage.

This funding opportunity supports innovative research on how communication between mitochondria and the nucleus affects Alzheimer’s Disease and related dementias, inviting applications from universities, nonprofits, and other organizations.

This funding opportunity provides support for the development and management of early-phase cancer prevention clinical trials, focusing on evaluating interventions to reduce cancer risk across various organ sites.

This funding opportunity provides support for research institutions to conduct early-phase clinical trials focused on cancer prevention interventions across various organ sites.

This funding opportunity provides financial support to various organizations, including health centers and nonprofits, to implement evidence-based strategies that increase colorectal cancer screening rates among underserved populations aged 45 to 75.

This funding opportunity provides financial support to research institutions for developing and sharing essential resources to advance the study of Polycystic Kidney Disease, fostering collaboration and innovation in the field.

This funding opportunity provides financial support to a single institution to establish a central coordinating site that will enhance collaboration and resource sharing among researchers focused on Polycystic Kidney Disease.

This program provides funding to Indiana communities and organizations to enhance recycling and waste reduction initiatives, requiring a 25% cash match from applicants.

This grant provides funding to national organizations focused on improving lupus awareness, diagnosis, treatment, and self-management among affected populations, particularly women aged 15 to 44.